News

MRC Global's Q3 2025 Performance: Growth Despite Challenges

MRC Global's Q3 2025 Performance: Growth Despite Challenges

Overview of MRC Global's Third Quarter Performance

In a recent announcement, MRC Global Inc. (NYSE: MRC) provided insights into its financial performance for the third quarter. The quarter revealed a total of $678 million in sales, marking a notable decrease of 15% when compared to the previous quarter of 2025.

Financial Highlights

Despite the decline in sales, MRC Global's performance metrics presented a mixed picture:

  • Gross profit margin stood at 18.4%, reflecting a decrease from the prior year.
  • Adjusted gross profit increased to 21.8% of sales.
  • The net loss from continuing operations was reported at $9 million.
  • Adjusted EBITDA reached $36 million, equivalent to 5.3% of sales.
  • The revenue backlog improved by 4% year-over-year, with U.S. segment backlog jumping by 21%.

Challenges Faced

Rob Saltiel, President and CEO of MRC Global, emphasized the challenges faced during the ERP system implementation in the U.S. segment, which impacted revenues and profitability. However, he expressed optimism about the future performance, indicating enhancements in financial metrics by the end of October.

Future Outlook

Kelly Youngblood, Executive Vice President and CFO, highlighted that the setbacks experienced were one-time occurrences related to the ERP system rollout. As invoicing normalizes, MRC Global anticipates releasing backlog growth into revenues, expecting mid-to-high single-digit revenue growth in the forthcoming quarter.

Merger with DNOW Inc.

Another significant development is the pending merger between MRC Global and DNOW Inc. This merger is expected to create a larger, more efficient enterprise, promising greater service offerings for customers and enhanced opportunities for team members.

Net Income Metrics

MRC Global recorded a net loss of $9 million for Q3 2025, down from a net income of $29 million in the same quarter of the previous year. Adjusted net income for the quarter was reported at $11 million.

Segment Performance

The breakdown of sales indicated that the U.S. segment faced the brunt of declines with sales at $550 million, a 15% drop compared to last year. However, the international segment fared slightly better, achieving $128 million in sales, up slightly by 1% from the prior year. This indicates diversification efforts may be yielding results as some segments perform better than others.

Sales and Backlog Insights

As of September 30, 2025, the overall backlog for the company stands at $571 million. This includes a substantial 21% increase in U.S. segment backlog, supporting the expectation of revenue recovery as challenges from the ERP implementation resolve.

Balance Sheet Analysis

The financial position at the end of the quarter reflected a cash balance of $59 million and a long-term debt of $476 million. The company used $36 million in continuing operations during Q3, which is as per the operational adjustments made during the transition period.

Share Repurchase Program

Though there is a share repurchase program authorized for $125 million, this has been suspended due to the ongoing merger discussions with DNOW. Overall, MRC Global navigates a transitional phase, preparing for future growth while addressing current operational challenges.

Frequently Asked Questions

What were MRC Global's total sales for Q3 2025?

MRC Global's total sales for Q3 2025 were $678 million, reflecting a 15% decrease from the previous quarter.

What is the major challenge faced by MRC Global during the quarter?

The major challenge faced during the quarter was the implementation of a new ERP system, which impacted revenue and profitability.

How does MRC Global plan to recover from the recent challenges?

MRC Global anticipates releasing backlog growth into revenues as invoicing returns to normalized levels, expecting revenue growth in Q4.

What is the status of the merger with DNOW Inc.?

The merger with DNOW Inc. is pending and is expected to close in the fourth quarter, enhancing MRC Global's operational scope.

What is MRC Global's gross profit margin for Q3 2025?

The gross profit margin for Q3 2025 was reported at 18.4%, down from the previous year.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Endeavour Mining Sees Significant Stake Notification from BlackRock

Updated Category News Views 141

Endeavour Mining and Major Shareholding Update Endeavour Mining plc is making headlines with its latest update regarding shareholders. Recently, the company received a notable notification from BlackRock, Inc., one of the world’s leading investment management firms. This announcement highlights BlackRock's interests in Endeavour Mining, showcasing the ongoing...

Continue Reading
Concerns Rise as Collaborative Leaders Depart Congress Rapidly

Updated Category News Views 48

New Findings on Congressional Collaboration Recently, an insightful report emerged emphasizing the ongoing shifts within Congress, revealing a notable trend that could hinder bipartisan efforts. The analysis underscores the departures of many collaborative members, dubbed 'bridgers', poised to leave their positions, thus raising alarms about the future of political...

Continue Reading
Latest Safety Recalls: Critical Updates on Consumer Products

Updated Category News Views 271

Consumer product recalls can ripple through markets faster than a bad earnings report. Back in mid-2024, we saw some significant shake-ups with companies like John Deere and Liberty Hardware facing public scrutiny over safety issues. For traders, these incidents aren’t just corporate headaches; they’re potential red flags on the balance sheets that could send stock...

Continue Reading
Investors Unite: ASP Isotopes Inc. Faces Major Legal Challenge

Updated Category News Views 118

Understanding the Legal Challenge Against ASP Isotopes Inc. The Schall Law Firm, recognized for its commitment to investor rights, has brought significant attention to a recent class action lawsuit involving ASP Isotopes Inc. (NASDAQ: ASPI). This lawsuit addresses serious allegations regarding the company's transparency and accuracy in reporting its technological...

Continue Reading
Elyce Arons: Keynote Speaker and Honorary Doctorate Recipient

Updated Category News Views 101

Elyce Arons to Speak at LIM College Commencement Elyce Arons, the Founder and CEO of Frances Valentine, is set to take the stage as the keynote speaker at the upcoming commencement ceremony for the Class of 2026 at LIM College. This prestigious event will highlight her journey and accomplishments within the fashion industry, inspiring graduates to chase their dreams....

Continue Reading